The nifty Support level is placed at 12880 followed by 12800. If Nifty starts going up, then the resistance level will be 12975 and 13025. While the Bank Nifty support level is placed at 29475 and 29050. If Bank Nifty starts going up, then the resistance level will be 29975 and 30125.
FII and DII data
Foreign Institutional Investors bought shares of Rs. 3071.93 crore while Domestic Institutional Investors sold shares of Rs. 2789.85 crore in Indian equity market on November 18, as per data NSE data.
F&O Ban on NSE
Bank of Baroda, BHEL, Canara Bank, Indiabulls Housing Finance, Idea, Jindal Steel & Power, RBL Bank, PNB, SAIL, Sun TV and Tata Steel and securities are under the F&O ban for tomorrow (Nov 19).
Latest Corporate Action
- Punjab & Sind Bank – Meeting of Board of Directors of the company is scheduled to be held on Nov 21 to offer, issue, create and equity shares up to Rs. 5500 crore to the Government of India by way of Preferential issue of equity shares.
- Siemens Limited – Meeting of Board of Directors is scheduled on November, 25 to announced audited standalone and consolidated financial results of the company for the Quarter ended September 30, 2020 and recommendation of dividend for the Quarter ended September 30, 2020.
- Rama Steel Tubes Limited – BWR Rating has assigned a long term rating of BWR BBB- (Stable) and Short term rating of BWR A3 to bank loan facilities of Rama Steel Tubes Limited.
- Future Lifestyle Fashions Limited – Crisil has downgraded the rating from CRISIL B to CRISIL C/CRISIL D along with continuation on “Rating Watch with Negative Implications ” on account of non-payment of interest and principal due on 09 Nov 20 on the company’s Non-Convertible Debentures.
- Pricol Limited – Meeting of Board of Directors of the company is scheduled to be held on Nov 19 to consider, discuss and decide inter alia, the terms and conditions of the Rights Issue such as the issue price, right entitlement ration, record date and other related matters.
- Pfizer Limited – The Company said on November 18 about COVID-19 vaccine with partner BioNTech SE was 95% effective in the clinical trial and companies may filing for emergency approval from USFDA (US drug Regulator) which means vaccine may available as early as possible by the end of this year.
Leave a Reply